Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,204 | -36,564 | -19,128 | -73,317 | -53,972 |
| Depreciation Amortization | -2,613 | -1,129 | -541 | -313 | 138 |
| Accounts payable and accrued liabilities | -1,318 | 493 | -1,520 | -389 | 867 |
| Other Working Capital | 3,119 | 3,883 | 1,815 | -568 | -1,909 |
| Other Operating Activity | 10,444 | 5,404 | 4,362 | 10,827 | 6,440 |
| Operating Cash Flow | $-43,572 | $-27,913 | $-15,012 | $-63,760 | $-48,436 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -47,192 | -13,597 | 49,801 | 6,616 | -18,245 |
| PPE Investments | -765 | -721 | -156 | -7,984 | -6,346 |
| Investing Cash Flow | $-47,957 | $-14,318 | $49,645 | $-1,368 | $-24,591 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35,289 | 2,143 | 12 | 958 | 410 |
| Financing Cash Flow | $35,289 | $2,143 | $12 | $958 | $410 |
| Beginning Cash Position | 109,119 | 109,119 | 109,119 | 173,289 | 173,289 |
| End Cash Position | 52,879 | 69,031 | 143,764 | 109,119 | 100,672 |
| Net Cash Flow | $-56,240 | $-40,088 | $34,645 | $-64,170 | $-72,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,572 | -27,913 | -15,012 | -63,760 | -48,436 |
| Capital Expenditure | -765 | -721 | -156 | -7,984 | -6,346 |
| Free Cash Flow | -44,337 | -28,634 | -15,168 | -71,744 | -54,782 |